{
    "eid": "2-s2.0-85102222105",
    "title": "Dabigatran or Aspirin After Embolic Stroke of Undetermined Source in Patients With Patent Foramen Ovale: Results From RE-SPECT ESUS",
    "cover-date": "2021-03-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology (clinical)",
            "@code": "2728",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Cardiology and Cardiovascular Medicine",
            "@code": "2705",
            "@abbrev": "MEDI"
        },
        {
            "@_fa": "true",
            "$": "Advanced and Specialized Nursing",
            "@code": "2902",
            "@abbrev": "NURS"
        }
    ],
    "keywords": [
        "aspirin",
        "dabigatran",
        "foramen ovale, patent",
        "meta-analysis",
        "stroke"
    ],
    "authors": [
        "Hans Christoph Diener",
        "Aurauma Chutinet",
        "J. Donald Easton",
        "Christopher B. Granger",
        "Eva Kleine",
        "Lars Marquardt",
        "Juliane Meyerhoff",
        "Andrea Zini",
        "Ralph L. Sacco"
    ],
    "citedby-count": 19,
    "ref-count": 10,
    "ref-list": [
        "Embolic strokes of undetermined source: The case for a new clinical construct",
        "Dabigatran for prevention of stroke after embolic stroke of undetermined source",
        "Rivaroxaban for stroke prevention after embolic stroke of undetermined source",
        "Patent foramen ovale closure, antiplatelet therapy or anticoagulation therapy alone for management of cryptogenic stroke? A clinical practice guideline",
        "Consensus statements and recommendations from the ESO-Karolinska Stroke Update Conference, Stockholm 11-13 November 2018",
        "Rivaroxaban or aspirin for patent foramen ovale and embolic stroke of undetermined source: A prespecified subgroup analysis from the NAVIGATE ESUS trial",
        "Design of Randomized, Double-Blind, Evaluation in Secondary Stroke Prevention Comparing the Efficacy and Safety of the Oral Thrombin Inhibitor Dabigatran Etexilate vs. Acetylsalicylic Acid in Patients with Embolic Stroke of Undetermined Source (RE-SPECT ESUS)",
        "Patent foramen ovale closure or anticoagulation vs. Antiplatelets after stroke",
        "Effect of medical treatment in stroke patients with patent foramen ovale: Patent Foramen Ovale in Cryptogenic Stroke Study",
        "Antithrombotic therapy for atrial fibrillation: CHEST guideline and expert panel report"
    ],
    "affiliation": [
        {
            "affiliation-city": "Ingelheim am Rhein",
            "@id": "60011807",
            "affilname": "Boehringer Ingelheim Pharma GmbH &amp; Co. KG",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60011807",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Hamburg",
            "@id": "60204093",
            "affilname": "Semmelweis University, Asklepios Campus Hamburg",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60204093",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bologna",
            "@id": "60033731",
            "affilname": "Ospedale Maggiore",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60033731",
            "affiliation-country": "Italy"
        },
        {
            "affiliation-city": "Durham",
            "@id": "60030982",
            "affilname": "Duke Clinical Research Institute",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60030982",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "San Francisco",
            "@id": "60023691",
            "affilname": "University of California, San Francisco",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60023691",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Miami",
            "@id": "60021519",
            "affilname": "University of Miami Leonard M. Miller School of Medicine",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60021519",
            "affiliation-country": "United States"
        },
        {
            "affiliation-city": "Duisburg",
            "@id": "60014264",
            "affilname": "Universit\u00e4t Duisburg-Essen",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014264",
            "affiliation-country": "Germany"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60002620",
            "affilname": "Faculty of Medicine, Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60002620",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Hamburg",
            "@id": "100621033",
            "affilname": "University Department of Neurology",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/100621033",
            "affiliation-country": "Germany"
        }
    ],
    "funding": [
        "Boehringer Ingelheim"
    ]
}